CBA China Frist Annual Conference in 2024

The Chinese Biopharmaceutical Association (CBA) China First Annual Conference is scheduled to convene on June 28, 2024, Sunday at Suzhou International Expo Center(Hall A, C-E). The conference will be held both in-person and online simultaneously.

Introduce of CBA

Chinese Biopharmaceutical Association-USA was established in 1995，it is the largest Chinese-American Biopharmaceutical association in USA，The primary purpose of CBA is to serve as a bridge for promote comprehensive exchanges and cooperation in the Biopharmaceutical fields between USA and China and provide a good environment for the development and cooperation of biopharmaceutical companies and scientific research institutions.

CBA is headquartered at Maryland in USA, which has branches in Boston, Philadelphia and Canada. It currently has more than 10,000 individual members and more than 1,000 corporate members. The members of CBA come from diverse sources which including emerging technology companies in USA and China、multinational pharmaceutical companies、colleges and universities、scientific research institutions、government medical review departments、various types of research or industrial development support funds、legal and intellectual property and other professional institutions. More than 80% of CBA members have doctoral degrees. Along with CBA’s growing contribution in the field of biopharmaceutical, more and more CBA members have made achievements in the scientific research and economic fields of China and USA. Many senior American scientists、successful entrepreneurs and even bioinvestors have become members of CBA. CBA has a good reputation internationally, with members all over the world, including China, USA, Europe, Canada, Australia, Singapore and Japan.

Among the past 28 years, CBA has always adhered to the mission of promoting exchanges and cooperation among biopharmaceutical professionals, and also committed to promote the development of the life and health industry, and effectively promoted business cooperation and partnerships between different countries and regions, especially between China and USA, It has become an incubator for talents and entrepreneurs, and cultivated the environment for collaborative growth, innovation among biopharmaceutical companies and research institutions. CBA has hosted or co-organized special workshops, seminars, annual meetings and social activities every year with other groups, it has become an platform which allow professionals to share professional knowledge and in-depth learning, lead industry development, build connections and seek career development. CBA has grown With the dedication of CBA members and the continuous support of partners and sponsors year by year.

CBA is working hard to further promote the exchange of biopharmaceutical talents and projects between China and USA and to develop and commercialize innovative pharmaceutical products. The content covers vaccines, new anti-tumor drugs and antibodies, nucleic acid drugs, human longevity and health, microbial molecular diagnosis, Gene therapy, artificial intelligenceand precision medicine, modern biopharmaceutical factories, laws and regulatory regulations, investment funds for various types of research or industrial development, which aim to meet the clinical needs of the global market for the treatment of various diseases and strive to serve patients in various aspects and benefit mankind. Among the ranks of innovation and entrepreneurship, a large number of outstanding hard-working entrepreneurs and investors have emerged among the presidents and members of CBA, and have achieved remarkable results. At the same time, they have made a positive contribution to the exchanges of scientific and technological , especially biopharmaceutical. In the future, the global biopharmaceutical and healthcare industries will still face many challenges and opportunities. CBA will forge ahead, actively prepare and meet new opportunities and challenges!

1. The theme of the conference

The first Annual Conference of Chinese Biopharmaceutical Association-USA 2024 in China

2. Time arrangement

Pre-conference meeting: afternoon of June 27, 2024

Conference: June 28-29, 2024

3. Conference locationSuzhou·International Expo Center (Hall A, Hall C, Hall D, Hall E) 

4. Scale of the Conference20,000+ participants 

5. Organizational structure

Sponsor: Chinese Biopharmaceutical Association (CBA-China)Co-organizers: National Biopharmaceutical Technology Innovation Center, Science and Technology Investment Center of Suzhou Industrial Park, BioBAYOrganizer: Suzhou Yuncheng WanchuanSupport unit: TBD 

6. Format of the conference

Pre-conference meetings, report, unveiling ceremonies, corporate product launches, entrepreneurial project roadshow competitions, corporate/cultural/cultural tourism exhibitions, cooperation project signings, talent settlement & corporate talent strategy, exchanges between Chinese and foreign institutions, business cooperation and exchanges, Jinji Lake Night – Cocktail parties, alumni associations, school alliances, corporate visits, etc. 

6.1 Pre-meeting

It adopts a seminar format, and participants include government representatives, experts from various forums, business representatives, international guests, regulatory agencies, financial institutions, advanced research institutions, clinical hospitals, etc. 

6.2 Report speech

1,000+ guests from china and abroad were invited to attend which include several Nobel Prize winners, as well as domestic and foreign academicians, experts and scholars, FDA medical review experts, representatives of outstanding entrepreneurs, regulatory agencies, advanced research institutions, clinical hospitals, investment and financing institutions, etc. , aim to inject new vitality and power into the development of the pharmaceutical field, and also promote innovation and progress, and thereby contribute to the development of the industry. 

6.3 unveiling ceremony

witness the unveiling of the CBA Suzhou branch at the opening ceremony of the conference 

6.4 Enterprise product launch conference

Demonstrations of new corporate products, research results, outstanding entrepreneurial projects are on display. Companies showcase their latest achievements and R&D products at the conference to gain more attention. 

6.5 Entrepreneurship Project Roadshow Competition

“Gather talents through competition, strengthen production through competition, and develop industry through competition”, connect multiple domestic and foreign investment institutions, activate the atmosphere of Biopharmaceutical entrepreneurship and investment, promote industrial innovation and development and ecosystem construction, and open up the efficient combination of enterprises and capital. Effectively transform and accelerate the implementation of high-quality Biopharmaceutical project results, build a communication and interaction platform for high-quality projects and investment institutions, and help entrepreneurs and companies grow rapidly. 

6.6 Corporate/cultural/cultural tourism exhibitions

6.6.1 Corporate exhibition

Exhibitions of corporate products, corporate business, corporate services and peripherals. CRO/CDMO/testing service companies, laboratory consumables companies, reagent materials, services, equipment and other companies receive good exhibition opportunities 

6.6.2 Suzhou characteristic cultural exhibition

Covering many Suzhou-specific cultural treasures such as Kunqu Opera, Pingtan, Song Brocade, Kesi, and Wumen calligraphy and painting, which display Suzhou’s rich and profound cultural charm in multi-dimensional and all-round way, and also will effectively promote the spread of local culture and let more people Appreciate the unique charm of Suzhou. 

6.6.3 Suzhou cultural tourism exhibition

Set up Thematic sections such as Suzhou Garden Tour and Ten Scenes of the Canal. Suzhou’s high-quality cultural and tourism resources, intangible cultural heritage and diverse Su-style lifestyles are presented to domestic and foreign guests Through interactive experiences, prize-winning Q&A and other forms, attracting more people visit Suzhou and driving cultural tourism consumption. 

6.7 Signing of cooperation projects

Give full play to the advantages of the conference platform, efficiently integrate resources and promote the park’s favorable policies and excellent business environment to high-quality enterprises, which aim to assist the park’s investment promotion work and promote the implementation of high-quality projects.

6.8 Talent implementation & corporate talent strategy

6.8.1 Talent implementation

The park is people-oriented and leads the country in attracting and supporting top talents. The combined advantages of policy support, scientific research investment, and industrial improvement have attracted talents such as top students from higher research institutions, returnees, and corporate executives to settle here, providing more powerful intellectual support for technological innovation in the park.

6.8.2 Corporate talent strategy

Gather high-precision talents in china and abroad, build a platform for enterprise and talent exchange, conduct face-to-face communication, recruit more outstanding talents for enterprises, meet the talent gap of enterprises, and serve the innovation and development of enterprises.

6.9 Exchanges between Chinese and foreign institutions

Attract teams from Chinese and foreign universities to participate in the conference, expand Suzhou’s “circle of friends” for international educational exchanges, promote personnel exchanges and in-depth cooperation in the field of education between the two sides, cultivate more world-oriented talents, and help create a “new business card” for Suzhou’s education opening to the outside world.

6.10 Business cooperation and exchanges

Face-to-face communication between the upstream and downstream of the industrial chain, face-to-face communication with corporate executives, and zero-distance communication to promote more cooperation.(Note: During the conference, corporate representatives gathered, business dinners, corporate receptions, countless)

 6.11 Jinji Lake Night-Cocktail Party (Time: June 28, 18:00-21:30)

An entrepreneur exchange reception will be held at the Moonlight Dock beside the Jinji Lake where has cultural market , Music, beautiful scenery, and night markets, creating a relaxed and pleasant communication atmosphere. Use wine as a medium to exchange ideas, broaden horizons, and discuss development together. 

6.12 Alumni Association

Michigan Alumni Association, Cambridge University Alumni Association, Peking University Alumni Association, Tsinghua Alumni Association, Fudan Alumni Association, China Pharmaceutical University Alumni Association, Shenyang Pharmaceutical University Alumni Association,Zhongshan University Alumni Association etc. 

6.13 College Alliance

College alliance signing ceremony. 

6.14 Company visits

Returnees, corporate executives, and high-precision talents are invited to visit the biopharmaceutical companies in the park. 

7. Organizing Committee

organizing Committee: Dajun Yang(first president of CBA-China Branch),Guoliang Yu,Yang Lu,Shoubai Chao,Song Wu,Jingyu Luan,You Li, Chunlin Chen, Lei Fu, Weiwu he, Yifan Zhai, Ziping Wei, Yingxian Xiao, Yuqi Zhao, Li Li, yuxin men, Qi Zeng, Hongjun Yang, Xuyang song, Zhao Wang, Ling Yang, Qing Liang, Jingke Weng, Yali Li, Hang Lu, Hao Cai, Qing Li, chuanhua Xing, Lin Sun, Dan Zhang, Chunhong Liu, Dewan Zeng, Yuling Li, Min Zhu, mengqi fan, Yuanjun Sun, ruyi he, Yaping Wang,Chao Liu, Lin Li, Ting Deng, Jiming Cai, Yumin Zhang, Peng Wang, Tong Guo, Ke Ding,  Liying Sun, Gengcheng Yang, Hui Feng Dadong Chen, Xiangyang Zhu, Gang Chen, Fei You, Yixing Han, haomeng Wang, Jinbo Gou, Changlin Tian,Leping Li,Jianfeng Xu, Jianyuan Tang,Xiang Li,Weijun Sha,Xinle Wu,Zhaojun Mo, Jianguang Li, Zhen Huang,Jinsong Guo, Shiqiao Zhu, Mingjiu Chen,Xun Liu,Yiping Rong,Peikun Zhao,Jinna Cai,Wenjie Li,Jianxiong Chu.Advisory Committee: to be determined

8. Agenda of the conference

Main venue: life and health

Session 1/2: Small molecule field

Topic 1: New Technology of Drug Screening and Practice of New Targets (Planner/Moderator: Weijun Sha)

 Topic 2: “Development of Non-drug Target Drugs and New Technology” (Planner/Moderator: Leping Li)

Topic 3: Targeted Protein Degradation Technology: PROTAC and Molecular Glue Technology (Planner/Moderator: Ke Ding)

Topic 4: “International and Domestic Perspectives: Opportunities and Challenges in the Research and Development of Small Molecule Drugs” (Planner/Moderator: Yuanjun Sun)

Topic 5: “Globalization Perspective-The Road of Small Molecules Innovative Drugs Going abroad” (Planner/Moderator: Tong Guo)

Topic 6: Differentiated Layout of New Non-tumor Drugs (Planner/Moderator: Jinsong Guo)

Session 3/4: Macromolecule Field

Topic 1: Discussion on the Development and Commercialization of Antibody and Protein Drugs (Planner/Moderator:Shiqiao Zhu)

 Topic 2: The New Trend of Combination Therapy of Immunotherapy (Planner/Moderator: Qi Zeng）

Topic 3: Platform of Emerging Antibody Discovery Technology (Planner/Moderator: Hui Feng/Xiangyang Zhu)

Topic 4: Development of Bispecific and Multispecific Antibodies (Planner/Moderator: Xuyang Song)

Topic 5: New Targets and Development of the First Antibody Drugs in the World (Planner/Moderator: Mingjiu Chen)

Topic 6: Selection and Development of Nanoantibodies (Planner/Moderator:Xun Liu)

Session 5/6: ADC field (Ziping Wei,Qing Li)

Topic 1: Innovation and Exploration of ADC Technology (Forum title: ChemExpress, TOT BIOPHARM) (planner/moderator: Qing Li)

Topic 2: Clinical Research and Challenges of ADC (planner/moderator:  Yixing Han)

Topic 3: ADC Coupling and Small Molecular Platform Innovation (Planner/Moderator: Fei You)

Topic 4: ADC’s Way to abroad and international cooperation(co-sponsored by ChemPartner)  (Planner/Moderator: Ziping Wei)

Topic 5: ADC Process Development and CMC (Planner/Moderator: Gengcheng Yang)

 Topic 6: ADC Translational Medicine Research and Biomarkers Exploration (Planner/Moderator: Chunhong Liu)

Session 7/8: Advanced Treatment Field (Yuling Li, Min Zhu)

Topic 1: “CXO Helps the Research and Commercialization of Advanced Therapeutic Drugs” (Planner/Moderator: Yuling Li)

Topic 2: Progress and Prospect of Next Generation Cell Therapy (Planner/Moderator: Min Zhu)

Topic 3: Progress and Prospect of Next Generation Cell Therapy (Planner/Moderator: Min Zhu)

Topic 4: Frontier Therapy (Moderator:Guoying Zhou )

Topic 5: Gene Therapy Vector Research and Gene Editing (Planner/Moderator:Yuling Li)

Topic 6:Gene Therapy Vector Research and Gene Editing (Planner/Moderator:Yuling Li)

Session 9: AI and new technologies (joint planning by DP Technology)

Topic 1: “The new Paradigm of AI and New Technology Empowering Biopharmaceutical research and development” (Planner/Moderator: Mengqi Fan)

Topic 2: Exploration and Promotion of AI Technology and digital health in Clinical Application, Drug Research and Life Sciences (Planner/Moderator: Xuyang Song)

Topic 3: “AI and New Technology Empowering New Targets, New Mechanisms and Frontier Biology Research” (Planner/Moderator: Mengqi Fan/Bingfeng Li)

Session 10/11: Vaccine field (Shoubai Chao, hang Lu)

Topic 1: The Development and Challenge of Innovative Vaccine (Planner/Moderator: Shoubai Chao)

Topic 2: Quality Management of Innovative Vaccines (Planner/Moderator: Zhaojun Mo)

Topic 3: New Vaccine Adjuvant and Carrier Technology (Planner/Moderator: Jianguang Li)

Topic 4: mRNA Vaccine and Drug Development (Planner/Moderator: Haomeng Wang)

Topic 5: “Innovative Development of Therapeutic Vaccine and Key Points of Regulation” (Planner/Moderator: Hang Lu)

Topic 6: Discussion on the Internationalization of Vaccines in China (Planner/Moderator: Jinbo Gou)

Session 12/13: Clinical field (Yuxin Men)

Topic 1: Interpretation of Policies and Regulations Related to Clinical Trials in China and America (Planner/Moderator: Yuxin Men)

Topic 2: Clinical Experiment I under the Background of Artificial Intelligence and Digital Transformation (Planner/Moderator: Ruyi He)

Topic 3: Clinical Experiment II under the Background of Artificial Intelligence and Digital Transformation (Planner/Moderator: Chao Liu)

Topic 4: Application of Real World Data in Clinical Research (Planner/Moderator: Yaping Wang)

Topic 5: Challenges and innovation in Clinical Operation (Planner/Moderator: Liying Sun)

Topic 6: Opportunities and Challenges from Innovative Clinical Trial Design (Planner/Moderator: Gang Chen)

Session 14: Investment and BD (Dewan Zeng)

Topic 1: ” Development of enterprise under the help of Investment and Merger” (Planner/Moderator: Dadong Chen)

Topic 2: Business Development and Cross-border Trading of Innovative Drugs (Planner/Moderator: Dewan Zeng)

Topic 3: Investment Map and Capital Structure of Pharmaceutical Innovation (Planner/Moderator: Dewan Zeng)

Session 15: Global Registration Declaration and Regulations (Li Li, Zhao Wang)

Topic 1: Strategy and Practice of Clinical Declaration for New Drugs in China and America(IND/CTA) (Planner/Moderator: Zhao Wang, Lin Li)

Topic 2: Strategic Planning of Dynamic Changes in Global Regulatory Supervision (Planner/Moderator: Dan Zhang, Li Li)

Topic 3: Strategy and Practice of China-US New Drug Listing Declaration (NDA/BLA) (Planner/Moderator: Li Li, Ting Deng)

Session 16: Polypeptide Forum

Topic 1: Development and Delivery System of Polypeptide Drugs (Planner/Moderator: Changlin Tian)

Topic 2: Process Development and Quality Research of Polypeptide Drugs (Planner/Moderator: Hong Li)

Topic 3: Commercial Production of Polypeptide Drugs (co-sponsored: Biochemistry of middle peptide)(Planner/Moderator: Xiang Li)

Session 17: Nucleic Acid Forum (co-sponsored by Medicilon Chunlin Chen)

Topic 1: Frontier Research on Nucleic Acid Drug Innovation (Planner/Moderator: Jinna Cai)

 Topic 2: Technological Development of Nucleic Acid Drugs (Planner/Moderator: Wenjie Li)

Topic 3: Industrialization Innovation of Nucleic Acid Drugs (Planner/Moderator: Jinna Cai)

Session 18: Nuclide Drugs Forum (Qing Liang)

Topic 1: Research and Development of Nuclide Drugs _R&D (Planner/Moderator: Yumin Zhang)

Topic 2: Production and Supply of Nuclides and Nuclide Drugs, CMC (Planner/Moderator: Jiming Cai)

Topic 3: Considerations of Clinical Design for Late Development of Nuclide Drugs (Planner/Moderator: Qing Liang)

Session 19: Future development direction of diet Drugs

Topic 1: Translational Medicine/Scientific Consideration of Diet Drugs (Planner/Moderator:  Jianfeng Xu)

Topic 2: New Targets and New Molecular Design (Planner/Moderator: Zhao Wang/Xinle Wu)

Topic 3: Clinical application of weight-loss drugs (Planner/Moderator: Tong Guo)

Session 20: Forum of Bottom Innovation for Nucleic Acid and the 11th International Conference of Drug Innovation on Nucleic Acid and protein Structural in Chemistry and Biology (planner/moderator: Zhen Huang)

Topic 1: A New Paradigm of biopharmaceutical research and development which Empowered by bottom Innovation of Nucleic Acid (Planner/Moderator: Huang Zhen)

Topic 2: The bottom discovery and Innovation Drive of Nucleic Acid-Protein Targets and Drug Structure (Moderator: Demin Zhou /Haitao Li)

Topic 3: The Bottom Discovery and Delivery innovation of Nucleic Acid-protein Vaccines and Other Nucleic Acid Drugs (Moderator: Haitao Li /David Lilley)

Session 21

Topic 1: The promotion on biopharmaceutical from Policy and Law (Planner/Moderator: Lin Sun /Yin Wang)

Topic 2 (morning): High-quality development of traditional Chinese medicine (curator:Jianyuan Tang)

Topic 2 (afternoon): Inheritance and Innovation of Traditional Chinese Medicine (Planner/Moderator: Jingke Weng /Haiying Xu)

Session 22 precision medicine

Topic 1: AI Precision Medicine and biopharmaceutical (Planner/Moderator: Chuanhua Xing)

Topic 2 (morning): Translational Medicine/Precision Medicine (Planner/Moderator: Yali Li)

Topic 2 (afternoon): Translational Medicine/Precision Medicine (Planner/Moderator: Hongjun Yang)

Session 23

Topic 1: Special Session of Philadelphia

Topic 2: CNS (Planner/Moderator: Peng Wang)

Topic 3: Special Session of Shenyang Pharmaceutical University Alumni Association

Session 24:

Topic1：Special Session of Fudan University Alumni Association

Topic2：Medical Devices (Planner/Moderator: Chu Jianxiong)

Session 25：

Topic1：Special Session of Zhongshan University Alumni Association

Topic2：CBIITA consortium symposium

Session 26：Pharmacopoeia Committee training meeting

Session 27：Conclave (Planner：New Drug Founders）

Session 28：The First Global Chinese Biopharmaceutical Entrepreneurship Competition of CBA(co-sponsored by CBA, Yuanhe Holdings, BioBAY and Shenghe Innovation Center, You Li)

Sponsors and Partners